[New antipsychotic drugs].
Weizer
M
M
Levy
A
A
Davidson
M
M
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D052160:Benzothiazoles; D002986:Clinical Trials as Topic; D003987:Dibenzothiazepines / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077487:Pramipexole; D011618:Psychotic Disorders / Q000188:drug therapy*; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use
D014150:Antipsychotic Agents; D052160:Benzothiazoles; D003987:Dibenzothiazepines; D007093:Imidazoles; D007211:Indoles; D010879:Piperazines; D013844:Thiazoles; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D010890:Pirenzepine; C092292:ziprasidone; D000077487:Pramipexole; C066304:sertindole; D018967:Risperidone; D000077152:Olanzapine